
### [NCIT:C9339](http://purl.obolibrary.org/obo/NCIT_C9339)
**Label:** Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified

**Subclasses:** 

**Class expressions from DL-Learner:**

- Thing 54.31%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 37.08%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40264](http://purl.obolibrary.org/obo/NCIT_C40264) (Vaginal Undifferentiated Carcinoma))) 37.08%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40263](http://purl.obolibrary.org/obo/NCIT_C40263) (Vaginal Small Cell Carcinoma))) 37.08%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40261](http://purl.obolibrary.org/obo/NCIT_C40261) (Vaginal Adenoid Cystic Carcinoma))) 37.08%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40260](http://purl.obolibrary.org/obo/NCIT_C40260) (Vaginal Adenosquamous Carcinoma))) 37.08%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C4026](http://purl.obolibrary.org/obo/NCIT_C4026) (Ovarian Mucinous Cystadenocarcinoma))) 37.08%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40259](http://purl.obolibrary.org/obo/NCIT_C40259) (Vaginal Villous Adenoma))) 37.08%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40258](http://purl.obolibrary.org/obo/NCIT_C40258) (Vaginal Tubulovillous Adenoma))) 37.08%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40257](http://purl.obolibrary.org/obo/NCIT_C40257) (Vaginal Tubular Adenoma))) 37.08%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40255](http://purl.obolibrary.org/obo/NCIT_C40255) (Vaginal Mullerian Papilloma))) 37.08%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40252](http://purl.obolibrary.org/obo/NCIT_C40252) (Vaginal Mucinous Adenocarcinoma))) 37.08%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40251](http://purl.obolibrary.org/obo/NCIT_C40251) (Vaginal Endometrioid Adenocarcinoma))) 37.08%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40248](http://purl.obolibrary.org/obo/NCIT_C40248) (Vaginal Warty Carcinoma))) 37.08%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40245](http://purl.obolibrary.org/obo/NCIT_C40245) (Vaginal Basaloid Carcinoma))) 37.08%


